LZ 8

Drug Profile

LZ 8

Alternative Names: Ling Zhi-8; Ling Zhi-i

Latest Information Update: 11 Feb 2008

Price : $50

At a glance

  • Originator Meiji Dairies Corporation
  • Class Antivirals
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Diabetes mellitus; Transplant rejection

Most Recent Events

  • 14 Jul 1998 No-Development-Reported for Diabetes mellitus in Japan (Unknown route)
  • 14 Jul 1998 No-Development-Reported for Transplant rejection in Japan (Unknown route)
  • 01 Dec 1995 Preclinical development for Diabetes mellitus in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top